What is Semax in research contexts?

Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment with extended stability via a C-terminal Pro-Gly-Pro tail. It is studied in preclinical models for cognitive endpoints, BDNF and NGF expression, and neuroprotection in cerebral ischemia.

How is Semax studied for attention research?

Semax is evaluated in rodent attention paradigms including the 5-choice serial reaction time task, sustained attention tasks, and impulsivity measures. Studies examine effects on attentional accuracy, premature responses, and integrated cognitive performance in attention-relevant models.

What ADHD-related models inform Semax research?

Models include spontaneously hypertensive rats (SHR, an ADHD-relevant strain), 6-OHDA neonatal lesion models of inattention, and pharmacological challenge models. Semax research in these contexts examines neurotrophic and behavioral mechanisms relevant to attention research.

Is Semax approved for human use?

No. Semax is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Where can researchers source third-party tested Semax?

Midwest Peptide supplies research-grade Semax with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Semax Attention Research

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

Semax Attention Research | Midwest Peptide

For Research Use Only. Semax is intended strictly for in vitro and preclinical animal research. It is not approved for human use, is not a drug, and should never be administered to humans.

Additional Mechanistic Context From the Published Literature

Beyond the behavioral attention literature reviewed above, the ACTH(4-10) backbone of semax engages the central BDNF/trkB system on a timescale that maps directly onto the attention paradigms. A peer-reviewed analysis published in Dolotov et al., Journal of Neurochemistry (Wiley Online Library), 2006 reported that a single 50 microgram per kilogram intranasal dose of semax produced a 1.4-fold rise in BDNF protein and a 1.6-fold rise in trkB tyrosine phosphorylation in the rat hippocampus within hours, with parallel 3-fold and 2-fold increases in exon III BDNF and trkB mRNA respectively. This neurotrophin window aligns with the time course over which improved selective attention and conditioned avoidance responses are observed in rodent models, providing a candidate molecular substrate for the behavioral observations and an experimental endpoint researchers can use to bridge molecular and behavioral readouts in the same animal cohort.

Attention as a Research Construct

Attention refers to the cognitive processes that select relevant information from the environment and sustain focus on it across time. The neural systems that support attention include the prefrontal cortex, the parietal cortex, the anterior cingulate cortex, and ascending neurotransmitter systems including dopaminergic, noradrenergic, and cholinergic projections. The integrated biology of attention has been studied extensively in both humans and animal models, with primary research archived at the Nature subject hub on attention and the Cell Press journal Cell Reports.

Attention deficits are a core feature of several conditions including ADHD, and rodent models that recapitulate aspects of ADHD biology have been developed for preclinical research. These models include the spontaneously hypertensive rat, which shows attention deficits and hyperactivity from a young age, and genetic models with modifications to dopaminergic or other neurotransmitter systems. Research on interventions that improve attention in these models provides preclinical data for considering attention related applications.

Semax Effects on Attention Measures

Published Semax research in rodent attention paradigms has used several behavioral tests including the five choice serial reaction time task, various sustained attention paradigms, and novel object recognition tests with attention components. The published findings document improvements in attention measures with Semax administration compared to vehicle controls.

The five choice serial reaction time task is a particularly informative paradigm because it measures attention directly through the response to briefly presented visual stimuli. Correct responses indicate successful attention to the stimulus. Errors of omission indicate failed attention. Errors of commission indicate impulsive responses without waiting for the stimulus. Semax administration has been reported to reduce both errors of omission and errors of commission in the task, which indicates improvement across the attention and impulse control domains.

The ScienceDirect attention topic page archives primary research on rodent attention paradigms that provides context for these findings.

Dopaminergic and Noradrenergic System Effects

The mechanisms underlying attention effects of Semax likely involve the dopaminergic and noradrenergic neurotransmitter systems that are central to attention biology. Published research has documented Semax effects on dopamine and norepinephrine metabolism in relevant brain regions, with the pattern consistent with enhanced catecholaminergic signaling during active Semax administration.

The BDNF upregulation that is a core Semax effect also interacts with the catecholaminergic systems because BDNF modulates the function and plasticity of catecholamine producing neurons. The combined effects on neurotrophic factors and on catecholamine signaling produce the integrated neural effects that underlie the attention behavioral findings.

The Wiley Online Library neuroscience collection and the Frontiers in Behavioral Neuroscience open access journal both archive primary research on the neural biology of attention that is useful for interpreting these findings.

The spontaneously hypertensive rat is one of the most widely used preclinical models for ADHD related research. The animals show baseline hyperactivity, attention deficits, and impulsivity from a young age that parallel core features of human ADHD. Research on interventions that improve these behavioral phenotypes in the model provides preclinical data on the intervention's potential attention enhancing effects.

Published Semax research in the spontaneously hypertensive rat and in related ADHD models documents improvements in attention endpoints, reductions in hyperactivity markers, and shifts in behavioral profiles toward the wild type comparator animals. The magnitude of effect varies across specific endpoints and across the details of the research protocols.

Genetic ADHD models with dopamine transporter modifications or other neurotransmitter system modifications have also been used. These models provide more mechanistic resolution than pharmacologically naive models because the specific system that is altered is defined by the genetics. Semax research in these models can link the behavioral findings to specific neurotransmitter systems through the genetic context.

The attention findings with Semax connect to research on related peptides covered in adjacent clusters. The Selank research cluster includes cognitive effects that partially overlap with the attention findings described here. The Selank versus Semax comparison article discusses the distinctions between the two compounds in cognitive and behavioral research.

For research specifically on attention, Semax has the more developed literature. For research on anxiolytic effects with cognitive components, Selank is more appropriate. The integrated use of both peptides in research programs can address the broader question of how related Russian nootropic peptides affect different aspects of cognition and behavior.

Age Verification

Semax Attention Research: ADHD-Related Rodent Behavioral Literature

Frequently Asked Questions

What is Semax in research contexts?

How is Semax studied for attention research?

What ADHD-related models inform Semax research?

Is Semax approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

Additional Mechanistic Context From the Published Literature

Attention as a Research Construct

Semax Effects on Attention Measures

Dopaminergic and Noradrenergic System Effects

Cognitive and Attention Integration

Intranasal Delivery Relevance

Research Peptide Referenced

Ready to Start Your Research?

Where can researchers source third-party tested Semax?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?

Age Verification

Semax Attention Research: ADHD-Related Rodent Behavioral Literature

Frequently Asked Questions

What is Semax in research contexts?

How is Semax studied for attention research?

What ADHD-related models inform Semax research?

Is Semax approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

Additional Mechanistic Context From the Published Literature

Attention as a Research Construct

Semax Effects on Attention Measures

Dopaminergic and Noradrenergic System Effects

ADHD Related Research Models

Comparison with Related Research Peptides

Cognitive and Attention Integration

Intranasal Delivery Relevance

Research Peptide Referenced

Related Research Reading

Related Research Articles

Explore Related Products

Ready to Start Your Research?

Where can researchers source third-party tested Semax?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?